JABEZ BARAJAS: Open Payments
NPI 1023652039 · GLENDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,359 in 99 payments from 23 companies in 2025. Trend: 2023 $1,680 · 2024 $1,473 · 2025 $2,359
Food & beverage: $2,359
| Company | Payments | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. | 8 | $427 |
| PFIZER INC. | 12 | $223 |
| Biogen, Inc. | 15 | $197 |
| Lilly USA, LLC | 4 | $173 |
| UCB, Inc. | 12 | $161 |
| ABBVIE INC. | 12 | $153 |
| Genentech USA, Inc. | 8 | $151 |
| Axsome Therapeutics, Inc. | 3 | $150 |
| Neurocrine BioSciences, Inc. | 3 | $147 |
| Teva Pharmaceuticals USA, Inc. | 4 | $143 |
Products named: ULTOMIRIS, NURTEC ODT, KISUNLA, Ocrevus Zunovo, Symbravo, INGREZZA, AUSTEDO XR, VUMERITY.
Industry payments across AZ — which companies pay providers there.
